|
CCDC90A expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.69369999999391E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.76773999999158E-05 |
| Normal-vs-Stage2 |
2.733600E-01 |
| Normal-vs-Stage3 |
3.22029999999529E-06 |
| Normal-vs-Stage4 |
3.83489999999931E-06 |
| Stage1-vs-Stage2 |
1.011990E-02 |
| Stage1-vs-Stage3 |
3.381800E-01 |
| Stage1-vs-Stage4 |
2.641200E-01 |
| Stage2-vs-Stage3 |
4.704700E-03 |
| Stage2-vs-Stage4 |
6.120200E-03 |
| Stage3-vs-Stage4 |
7.286200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.11010000040046E-07 |
| Normal-vs-AfricanAmerican |
3.302200E-03 |
| Normal-vs-Asian |
1.53587999999205E-05 |
| Caucasian-vs-AfricanAmerican |
9.610800E-01 |
| Caucasian-vs-Asian |
4.354000E-01 |
| AfricanAmerican-vs-Asian |
6.520800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.03299999995888E-06 |
| Normal-vs-Female |
5.80030000000287E-05 |
| Male-vs-Female |
5.453000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.18819999994635E-06 |
| Normal-vs-Age(41-60Yrs) |
2.86719999997853E-06 |
| Normal-vs-Age(61-80Yrs) |
6.904900E-03 |
| Normal-vs-Age(81-100Yrs) |
1.769600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.712000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.608400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.682000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.023580E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.305400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.982800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
2.885800E-02 |
| Classical-VS-Follicular |
1.21325172131037E-12 |
| Classical-VS-Other |
9.849800E-01 |
| Classical-VS-Normal |
1.76960002207238E-09 |
| Tall-VS-Follicular |
3.3886227157609E-12 |
| Tall-VS-Other |
1.963220E-01 |
| Tall-VS-Normal |
4.93520002642356E-09 |
| Follicular-VS-Other |
1.702180E-02 |
| Follicular-VS-Normal |
3.901000E-01 |
| Other-VS-Normal |
1.839600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.515300E-03 |
| Normal-vs-N1 |
1.84749999965206E-07 |
| N0-vs-N1 |
9.432400E-04 |
|
|
